First-line chemotherapy for ovarian cancer - the controversy continues

被引：2
|
作者：
Kaye, SB [1 ]
机构：
[1] Royal Marsden Hosp, Inst Canc Res, Sutton, Surrey, England
来源：
BRITISH JOURNAL OF CANCER | 2002年 / 87卷 / 08期
关键词：
D O I：
10.1038/sj.bjc.6600568
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：813 / 814
页数：2
相关论文
共 50 条
  • [41] First-line treatment of ovarian cancer: Proof and promise
    Runowicz, CD
    GYNECOLOGIC ONCOLOGY ISSUES IN THE 8TH IGCS MEETING OF BUENOS AIRES, 2000, : 3 - 6
  • [42] Bevacizumab in the First-line Treatment of advanced Ovarian Cancer
    Mallmann, Michael R.
    Alakus, Hakan
    Mallmann, Peter
    Bruns, Christiane
    ONKOLOGE, 2019, 25 (11): : 1020 - 1021
  • [43] Procedures after first-line treatment of ovarian cancer
    Thomssen, C
    ONKOLOGIE, 1999, 22 : 27 - 28
  • [44] Brain structure and function in patients with ovarian cancer treated with first-line chemotherapy: a pilot study
    D. D. Correa
    J. C. Root
    M. Kryza-Lacombe
    M. Mehta
    S. Karimi
    M. L. Hensley
    N. Relkin
    Brain Imaging and Behavior, 2017, 11 : 1652 - 1663
  • [45] Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer
    Xin-Ru Li
    Xing-Han Cheng
    Guo-Nan Zhang
    Xiao-Xin Wang
    Jian-Ming Huang
    Journal of Ovarian Research, 15
  • [46] Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy
    M K Tuxen
    G Sölétormos
    P Dombernowsky
    British Journal of Cancer, 2001, 84 : 1301 - 1307
  • [47] First-line chemotherapy with weekly paclitaxel and carboplatin for advanced ovarian cancer: A phase I study
    Sehouli, J
    Stengel, D
    Elling, D
    Ortmann, O
    Blohmer, J
    Riess, H
    Lichtenegger, W
    GYNECOLOGIC ONCOLOGY, 2002, 85 (02) : 321 - 326
  • [48] Ranked importance of outcomes of first-line versus repeated chemotherapy among ovarian cancer patients
    Vanessa L. Beesley
    Alexandra M. Clavarino
    Penelope M. Webb
    David K. Wyld
    Alessandra B. Francesconi
    Keith R. Horwood
    James D. Doecke
    Colleen A. Loos
    Adele C. Green
    Supportive Care in Cancer, 2010, 18 : 943 - 949
  • [49] Dose-dense first-line chemotherapy in advanced ovarian cancer: How to select the patients?
    Tjulandina, Alexandra
    Stenina, Marina
    Pokataev, Ilya
    Fedyanin, Mikhail
    Tryakin, Alexey
    Tjulandin, Sergei
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [50] DURATION OF FIRST-LINE CHEMOTHERAPY IN METASTATIC BREAST CANCER
    Gennari, Alessandra
    Provinciali, Nicoletta
    BREAST, 2015, 24 : S31 - S31
12345